Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Report - Industry stakeholder feedback on engagement and communication activities
Organisation chart: Task Forces
Emergency Task Force (ETF)
Composition of the Emergency Task Force (ETF) for preparedness
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Date of authorisation: 25/08/2025, Revision: 1, Status: Authorised
HMA-EMA joint Network Data Steering Group meeting - 6 November 2025
Funding
List of centrally authorised products with safety-related changes to the product information